The potential risks of pancreatitis and pancreatic cancer with GLP‐1‐based therapies are far outweighed by the proven and potential (cardiovascular) benefits
Year: 2013
Type: review
Source: Diabetic Medicine
DOI: 10.1111/dme.12301
Author: R. E. J. Ryder
Institution: Birmingham City Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2103487864
